Disseminated strongyloidiasis in an immunocompromised host:A case report

Infections caused by Strongyloides stercoralis (S. stercoralis) in human are generally asymptomatic, however in immunocompromised individual, hyperinfection may develop with dissemination of larvae to extra-intestinal organs. The diagnosis could be easily missed due to asymptomatic presentation and insufficient exposure towards the infection itself, which may lead to low index of suspicion as a consequence. In this report, a case of a Malaysian male with underlying diabetes mellitus, hypertension, cerebrovascular ac-cident, bullous pemphigus and syndrome of inappropriate antidiuretic hormone secretion who initially complained of generalized body weakness and poor appetite without any history suggestive of sepsis is presented. However, he developed septicemic shock later, and S. stercoralis larvae was incidentally found in the tracheal aspirate that was sent to look for acid fast bacilli. Regardless of aggressive resuscitation, the patient succumbed due to pulmonary hemorrhage and acute respiratory distress syndrome. It was revealed that the current case has alarmed us via incidental finding of S. stercoralis larvae in the tracheal aspirate, indicating that the importance of the disease should be emphasized in certain parts of the world and population respectively.

Disseminated strongyloidiasis in an immunocompromised host: A case report

Infections caused by Strongyloides stercoralis (S. stercoralis) in human are generally asymptomatic, however in immunocompromised individual, hyperinfection may develop with dissemination of larvae to extra-intestinal organs. The diagnosis could be easily missed due to asymptomatic presentation and insufficient exposure towards the infection itself, which may lead to low index of suspicion as a consequence. In this report, a case of a Malaysian male with underlying diabetes mellitus, hypertension, cerebrovascular accident, bullous pemphigus and syndrome of inappropriate antidiuretic hormone secretion who initially complained of generalized body weakness and poor appetite without any history suggestive of sepsis is presented. However, he developed septicemic shock later, and S. stercoralis larvae was incidentally found in the tracheal aspirate that was sent to look for acid fast bacilli. Regardless of aggressive resuscitation, the patient succumbed due to pulmonary hemorrhage and acute respiratory distress syndrome. It was revealed that the current case has alarmed us via incidental finding of S. stercoralis larvae in the tracheal aspirate, indicating that the importance of the disease should be emphasized in certain parts of the world and population respectively.

Falla orgánica múltiple por estrongiloidiasis diseminada: Comunicación de un caso / Multiple-organ dysfunction caused by dissemination of Strongyloides stercoralis infection: A case report

We report here the case of a 50-year-old male patient, from a rural setting, with past history of alcoholism. He was admitted in the Intensive Care Unit due to a worsening health status after a febrile syndrome of 25 days. In addition, he had diarrhea, intense muscle ache predominantly on upper extremities and abdomen, weight loss, confusion, seizures, psychomotor agitation, tachycardia, tachipnea, anuria, septic shock, coma, and multiple-organ dysfunction syndrome. The hyperinfection syndrome caused by Strongyloides stercoralis was suspected because of severe eosinophilia (52 percent of peripheral blood leukocytes). This diagnosis was verified by the parasitological examination of stool samples by direct wet mount and Baermann techniques. Treatment with thiabendazole at 25 mg/kg per day was started, as well as cefepime, vasoactive drugs, artificial mechanic ventilation, and hemodialysis. The patient died 12 hours after admission, probably due to secondary infection with Escherichia coli.

Se presenta el caso de un paciente masculino, de 50 años, con antecedentes de alcoholismo, procedente de área rural, que ingresó en la Unidad de Cuidados Intensivos por agravamiento de su estado general después de un síndrome febril de 25 días de evolución, presentando shock séptico, coma y falla orgánica múltiple. Se sospechó un síndrome de hiperinfección por Strongyloides stercoralis ante la presencia de una eosinofilia importante (52%), diagnóstico que fue confirmado con el examen parasitológico de las heces. Se inició tratamiento con tiabendazol a 25 mg/ kg al día, cefepima, fármacos vasoactivos, ventilación mecánica y hemodiálisis. Falleció 12 horas después del ingreso, posiblemente a causa de una infección secundaria por Escherichia coli.

Risk factors for acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in south India.

Purpose: Strongyloides stercoralis causes persistent and fatal disseminated infections in immunocompromised hosts. In this study, we aimed to determine the risk factors for acquiring strongyloidiasis and the associated morbidity in south India. Materials and Methods: The study was carried out in two parts. This included a 6-month chart review of cases with strongyloidiasis and randomly selected controls conducted to determine the association with immunocompromised states. Secondly, a cross-sectional study was conducted to investigate hyperinfection in human immunodeficiency virus (HIV)-infected adults where the stool and sputum samples were examined by microscopy for Strongyloides larvae. Results: In the chart review, 118 cases were compared with 240 controls. A higher proportion of patients on corticosteroids [8 (53.3%)] and with HIV infection [3 (60%)] had the risk of acquiring strongyloidiasis than not, although the difference was not statistically significant in this population. In the cross-sectional study, 14/239 HIV-positive individuals had Strongyloides larvae in the stool samples but none had Strongyloides detectable in their sputum samples. The CD4 cell counts were significantly lower in cases with Strongyloides compared with HIV-infected individuals with no parasites in their stool samples (P < 0.001). Conclusions: In this setting, strongyloidiasis was seen more often in patients on corticosteroid therapy and with HIV infection. In HIV, an association with lower CD4 counts indicates the need for inclusion of Strongyloides as an opportunistic parasite. Gram negative sepsis was an important complication of strongyloidiasis hyperinfection in both HIV and steroid therapy. Further prospective studies on the risk of developing complicated Strongyloides infection are required.

Fatal Strongyloides stercoralis hyper-infection in a patient with multiple myeloma

Strongyloides stercoralis (S.S.) is a human intestinal parasite, which may lead to complicated strongyloidiasis. We report a case of disseminated strongyloidiasis following the treatment of myeloma. The patient developed skin lesions, respiratory distress, aseptic meningitis and bacterial and fungal sepsis. The diagnosis of strongyloidiasis was established through endotracheal tube secretions. Despite the treatment with Ivermectin and Albendazole, the outcome was fatal. The value of screening for strongyloidiasis is unclear but may be of benefit in patients with hematological malignancies from high endemic areas.

Estrongiloidíase disseminada: diagnóstico e tratamento: [revisão] / Disseminated strongyloidiasis: diagnosis and treatment: [review]

JUSTIFICATIVA E OBJETIVOS: A estrongiloidíase disseminada é uma entidade clínica relacionada a estados de imunossupressão como os que ocorrem na síndrome da imunodeficiência aguda (SIDA), nas neoplasias hematológicas e nos tratamentos imunossupressores. Sua ocorrência e gravidade são mais freqüentes em pacientes usando elevadas doses de corticosteróides. A estrongiloidíase disseminada se apresenta habitualmente sob a forma de sepse grave. Essa apresentação clínica inespecífica representa grandes desafios relacionados ao diagnóstico e tratamento, resultando em elevada taxa de mortalidade. O diagnóstico depende de elevada suspeição clínica e da identificação da larva em amostras de fluidos ou tecidos. O envolvimento cutâneo é raro, entretanto por ser característico pode incrementar a possibilidade da hipótese diagnóstica. O objetivo deste estudo foi rever na literatura os aspectos clínicos da estrongiloidíase disseminada, destacando os métodos de diagnóstico e tratamento e ressaltar a importância da suspeição clínica para a profilaxia e tratamento adequados. CONTEÚDO: Foi realizada uma busca sistemática nos últimos 30 anos através da PubMed utilizando os termos disseminated strongyloidiasis, strongyloides and hyperinfection e ivermectin. CONCLUSÕES: Recentes avanços ocorreram na área terapêutica e dentre eles destaca-se o uso da ivermectina. O seu surgimento mudou significativamente o tratamento para estrongiloidíase, no entanto a administração por via oral ou enteral desse fármaco representou importante limitação para sua utilização em pacientes com íleo ou estado de hipoperfusão tecidual. Relatos de resultados positivos com o uso de ivermectina parenteral levantaram a possibilidade de essa modalidade terapêutica ser mais eficaz nas formas graves. No entanto questões relativas à posologia e segurança ainda precisam ser elucidadas.

BACKGROUND AND OBJECTIVES: Disseminated strongyloidiasis is a clinical form of presentation associated with states of severe immunosuppression, as in AIDS, hematological malignancies and in treatment for immunosuppression (especially with high doses of corticosteroids). It usually mimics severe sepsis and still brings a significant challenge related to the diagnosis and treatment. Therefore exceedingly high mortality rates remain unchanged in the past decades. Initially, the diagnosis depends on the clinical suspicion and on the identification of the larva in an organic fluids or tissues. The cutaneous involvement, albeit rare, is typical and can provide an important clue for the diagnostic hypothesis. The emergence of ivermectin for oral use changed significantly the treatment for strongyloidiasis; however, there are still shortcomings for the utilization in critically ill patients. Shock, ileus and hypoperfusion states are associated with difficulties in the absorption that result in erratic systemic levels. Reports of good results with parenteral administration of ivermectin raised the prospect that this therapeutic modality be more effective. However, questions about dosage and safety remain unanswered. The aim of the present article is to review the medical literature on the clinical aspects of disseminated strongyloidiasis. CONTENTS: A systematic review of the literature was performed by searching the PubMed database within the last 30 years. Search terms were: disseminated strongyloidiasis, strongyloides and hyperinfection e ivermectin. CONCLUSIONS: The article highlights the diagnostic and therapeutic aspects emphasizing the importance of the clinical suspicion for the institution of appropriated therapy.